Head of Division:
The division EuB represents two main quantitative methodological disciplines in medicine. In addition, we also work on the content of our own research fields. In teaching and research, we feel committed to the principles of evidence-based medicine and would like to contribute to better health care in the region and beyond. Our main areas of research are closely interlinked.
In the field of clinical epidemiology (Prof. A. Timmer) there are several methodological foci: On the one hand, we carry out survey-based projects on the care of chronic diseases. For this purpose, suitable disease-specific instruments are developed and validated. On the other hand, we have special expertise in the area of systematic reviews. For this purpose, we cooperate with Cochrane Germany. In the area of validation of routine data, we work on internationally integrated projects for the validation of hospital discharge diagnoses in the context of multicentre drug safety studies. In addition, we are particularly committed to the application of clinical epidemiology methods in cooperation with clinical and extra-curricular partners. Innovative study designs and surveys in the context of intervention studies in community settings are of particular interest. Currently we are Co-PI in the EU funded project MIDDEL.
The field of cancer epidemiology (NN) arises from the cooperation with the Epidemiological Cancer Registry of Lower Saxony as well as from the high relevance of oncology in everyday health care in the region. Current projects, for example, with the Centre for Cancer Registry Data at the Robert Koch Institute (Berlin), the Department of General and Visceral Surgery at the Pius Hospital Oldenburg (PD Dr. Weyhe) and the Cancer Epidemiology Department at the University Medical Centre Groningen (Prof. de Bock) are being worked on.
In the area of biometric methods (Dr. Fabian Otto-Sobotka), methods for modelling patient-relevant measurements in the context of health care research are applied and further developed. Application examples are mobility measures in the project Äquipa, or patient satisfaction from the project Transition. The progression-free survival times of patients with mutated lung cancer beyond a mean value are also being investigated in the DFG project VREIZEIT using data from the University Clinic for Haematology and Oncology at the Pius Hospital Oldenburg. The problem of missing values in longitudinal EEG data is investigated in experiments of the Department of Assistance Systems and Medical Device Technology.